TY - JOUR
T1 - Authors' response to Hogan
AU - Haagmans, Bart L.
AU - Osterhaus, Albert D.M.E.
PY - 2006/9/26
Y1 - 2006/9/26
N2 - In response to our Perspective on nonhuman primate models for SARS, which accompanied the article by Lawler et al., Robert Hogan questions the usefulness of nonhuman primates as good models for SARS.
As demonstrated by several groups, SARS coronavirus (SARS-CoV) replicates to high titers in the respiratory tract of a surprisingly broad range of animal species, albeit showing remarkable differences in cell tropism. We have argued that efficient infection of type 1 and 2 pneumocytes as seen in macaques and humans—most likely due to the similarities in the spike protein binding domains of the host SARS-CoV receptor ACE2—is a prerequisite for the SARS-CoV infection–induced pathology observed in humans. So far there is no strong evidence that a similar tropism is observed in other animal species.
[...]
AB - In response to our Perspective on nonhuman primate models for SARS, which accompanied the article by Lawler et al., Robert Hogan questions the usefulness of nonhuman primates as good models for SARS.
As demonstrated by several groups, SARS coronavirus (SARS-CoV) replicates to high titers in the respiratory tract of a surprisingly broad range of animal species, albeit showing remarkable differences in cell tropism. We have argued that efficient infection of type 1 and 2 pneumocytes as seen in macaques and humans—most likely due to the similarities in the spike protein binding domains of the host SARS-CoV receptor ACE2—is a prerequisite for the SARS-CoV infection–induced pathology observed in humans. So far there is no strong evidence that a similar tropism is observed in other animal species.
[...]
UR - https://www.scopus.com/pages/publications/33749024474
U2 - 10.1371/journal.pmed.0030415
DO - 10.1371/journal.pmed.0030415
M3 - Comment/Letter to the editor
AN - SCOPUS:33749024474
SN - 1549-1277
VL - 3
SP - 1657
EP - 1658
JO - PLoS Medicine
JF - PLoS Medicine
IS - 9
ER -